Phase 3 and Extensional Study of Besifovir
NCT01937806
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
197
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
besifovir 150mg
DRUG:
tenofovir 300mg
Sponsor
IlDong Pharmaceutical Co Ltd